Immuron

Immuron company information, Employees & Contact Information

Explore related pages

Related company profiles:

Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases. ACCEPTABLE USE POLICY We welcome your comments on our page but we ask that you help us comply with the Therapeutic Goods Advertising Code. Please consider these guidelines before commenting. We will remove any comments that may result in us breaching the Code. We love when you comment and tag your friends and family on our posts but we ask that you do not: • endorse our product if you are: o an employee or contractor of a government authority, a hospital or a healthcare facility o a health practitioner, health professional or medical researcher o involved with the production, sale, supply or marketing of our product o not using your own name on this social media platform • imply that a government authority, a hospital or a healthcare facility endorse our product • make comments about how a product works for you outside of its intended purpose, as these comments can be dangerous or misleading - our products are developed for particular purposes, as stated on the label and/or in our advertising • make comments about serious conditions, diseases, ailments or defects, such as comments about how a product helped with your treatment of a serious disease or how it will relieve a tagged person's serious condition We also have an obligation to make sure any advertisements we make, including endorsements and testimonials, are not misleading. Therefore we promise to disclose: • where a person has been, or will be, compensated for making a testimonial • where we have actors making the testimonial, such as in cases where the original person who made the testimonial does not want to appear in our advertisement • where the person making the testimonial is an immediate family member of anyone employed by our company.

Company Details

Employees
16
Address
Suite 10- 25 Chapman Street, Blackburn North,united States
Phone
610398245254
Email
in****@****ron.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Melbourne, Victoria
Looking for a particular Immuron employee's phone or email?

Immuron Questions

News

Immuron Q1 FY26 YoY growth - Yahoo Finance

Immuron Q1 FY26 YoY growth Yahoo Finance

Immuron Limited Reports Q1 Sales Growth of 34% Driven by Increased Demand for Travelan® - Quiver Quantitative

Immuron Limited Reports Q1 Sales Growth of 34% Driven by Increased Demand for Travelan® Quiver Quantitative

US$400M Potential: Immuron Submits IND for IMM-529 to FDA to treat C. difficile as oral therapy - Stock Titan

US$400M Potential: Immuron Submits IND for IMM-529 to FDA to treat C. difficile as oral therapy Stock Titan

Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target - TradingView

Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target TradingView

Immuron Letter to Shareholders – Projects Update - Yahoo Finance

Immuron Letter to Shareholders – Projects Update Yahoo Finance

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Immuron: Targeted oral antibodies to treat infectious diseases Innovation News Network

$400M Market Potential: Immuron's C. Difficile Drug IMM-529 Heads to FDA as Company Advances 3 Key Programs - Stock Titan

$400M Market Potential: Immuron's C. Difficile Drug IMM-529 Heads to FDA as Company Advances 3 Key Programs Stock Titan

Immuron Limited Reports Record Sales Growth for Travelan® with FY25 Sales Reaching AUD$7.3 Million - Quiver Quantitative

Immuron Limited Reports Record Sales Growth for Travelan® with FY25 Sales Reaching AUD$7.3 Million Quiver Quantitative

Immuron Crushes Sales Forecast: North America Soars 76%, Global Revenue Breaks Records at $7.3M - Stock Titan

Immuron Crushes Sales Forecast: North America Soars 76%, Global Revenue Breaks Records at $7.3M Stock Titan

Immuron partners with InvestorHub - GlobeNewswire

Immuron partners with InvestorHub GlobeNewswire

Immuron Reports Record A$7M Sales While 3 Key Clinical Programs Hit Major Milestones - Stock Titan

Immuron Reports Record A$7M Sales While 3 Key Clinical Programs Hit Major Milestones Stock Titan

Immuron Letter to Shareholders: Projects Update - GlobeNewswire

Immuron Letter to Shareholders: Projects Update GlobeNewswire

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Yahoo Finance

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) Yahoo Finance

Immuron Travelan® continued strong sales growth - FinancialContent

Immuron Travelan® continued strong sales growth FinancialContent

Immuron Board Changes - Yahoo Finance

Immuron Board Changes Yahoo Finance

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan® - Yahoo Finance

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan® Yahoo Finance

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - Yahoo Finance

Immuron Plans Phase 2 Trial for IMM-529 following FDA review Yahoo Finance

Immuron Limited Issues Correction to Misleading Halt Announcement Headline - GlobeNewswire

Immuron Limited Issues Correction to Misleading Halt Announcement Headline GlobeNewswire

IMC Stock Price and Chart — ASX:IMC - TradingView

IMC Stock Price and Chart — ASX:IMC TradingView

Top Immuron Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant